UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). SHOW MORE
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 October 6, 2021 Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic...
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: September 20, 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release....
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: February 27, 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™ More information
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: September, 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced by glatiramer...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....